The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Table. 1.

Table. 1.

Pattern and average tracking period days of acquiring anti-mycobacterial resistance in susceptible M. tuberculosis using the phenotypic susceptibility

Anti-tuberculosis drugs No. of patient (%) Tracking period days
Minimum Maximum Average
AMK 2 (0.3) 470 1,678 1,074.0
INH 20 (3.4) 98 978 293.6
QUI 2 (0.3) 377 1,243 810.0
RIF 6 (1.0) 141 657 351.0
SM 3 (0.5) 97 586 266.7
INH, RIF 10 (1.7) 133 1,673 591.9
INH, SM 4 (0.7) 297 1,862 866.3
INH, RIF, AMK 1 (0.2) - - 483.0
INH, RIF, EMB 2 (0.3) 155 505 330.0
INH, RIF, QUI 1 (0.2) - - 504.0
INH, RIF, SM 2 (0.3) 203 543 373.0
INH, SM, PAS 1 (0.2) - - 818.0
INH, PTH, QUI 1 (0.2) - - 154.0
INH, RIF, SM, EMB, PZA 1 (0.2) - - 108.0

Abbreviations: INH, isoniazid; RIF, rifampin; SM, streptomycin; QUI, quinolone; AMK, amikacin; EMB, ethambutol; PAS, para-aminosalicylic acid; PZA, pyrazinamide; PTH, prothionamide.

Korean J Clin Lab Sci 2021;53:137-42 https://doi.org/10.15324/kjcls.2021.53.2.137
© 2021 Korean J Clin Lab Sci